CRG (formerly Capital Royalty L.P.) is a healthcare-focused private credit and investment firm founded in 2003, providing growth capital primarily through structured debt to healthcare companies. The firm manages over $4 billion in total institutional capital across multiple funds; its latest fund, CRG Partners IV, closed at approximately $1.1 billion.
60% of their portfolio is in Healthcare. Their most common stage is series-b (40% of deals). Average disclosed round size is $49.3M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 EndoGastric Solutions, Inc. | Series B | $30.5M | Jul 2018 |
| SSilk Road Medical, Inc. | Unknown | $47M | Jul 2017 |
 EarLens | Series C | $73M | Jun 2017 |
| IIntrinsic Therapeutics | Series B | $49M | May 2017 |
 Silk Road Medical | Unknown | $47M | — |
Top Co-Investors
New Enterprise Associates2 shared
SightLine Partners2 shared
The Vertical Group2 shared
Warburg Pincus LLC2 shared
Norwest Venture Partners2 shared
Greenspring Associates1 shared
Delos Capital1 shared
Quadrille Capital1 shared
Bling Capital1 shared
Scale Venture Partners1 shared
Lightstone Ventures1 shared
Medtronic1 shared
Windham Capital Partners1 shared
Insight Partners1 shared
Radius Capital1 shared
Canaan Partners1 shared
Advanced Technology Ventures1 shared
Chicago Ventures1 shared
Last updated: 9 September 2026